1st Quarter - Report

MUSCULAR DYSTROPHY ASSOCIATION, INC. for MUSCULAR DYSTROPHY ASSOCIATION, INC.

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; rehabilitation research; regulatory pathway for biosimilars -HR 3590 Patient Protection and Affordable Care Act (P.L. 111-148); research and treatment of spinal muscular atrophy -HR 2149/S 1158; the Community Living Assistance Services and Supports Act -HR 1721/S 697; Competitive Bidding Repeal -HR 3790; and H1N1 distribution plans for high priority groups

LobbyistCovered position, as disclosed
DAVID MILLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2149 (111th), H.R. 1721 (111th), H.R. 3790 (111th), H.R. 3590 (111th)

Budget/Appropriations BUD

Funding for amyotrophic lateral sclerosis in the Fiscal Year 2011 Department of Defense appropriations bill

LobbyistCovered position, as disclosed
DAVID MILLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.